New resveratrol analogues for potential use in diabetes and cancer.

Date

2018-07-05

Advisors

Journal Title

Journal ISSN

ISSN

2574-1241

Volume Title

Publisher

biomedres

Type

Article

Peer reviewed

Yes

Abstract

Resveratrol is a well notorious compound that may play a role in the prevention of diabetes complications and different cancers. Along, resveratrol, a naturally occurring phytoalexin, is known to exert numerous beneficial effects in the organism. Isolation of resveratrol from plants, however, has been proved being difficult. Importantly, the bioavailability in the body is poor therefore capability is reduced and not enough resveratrol reaches the target organ. In this study we generated different methoxylated resveratrol analogues using Wittig reaction. Trans stilbene obtained was 0.08 g and the cis one was 0.01 g. Additionally with the Horner-Witting method a yield of 0.15 g trans stilbene was obtained. By substituting the hydroxyl group with methoxy group at different positions on the aromatic rings, we could increase the efficacy and bioavailability of the Trans form of resveratrol.

Description

open access journal

Keywords

Cancer, Diabetes, Horner-Wittig Reaction, Resveratrol, Stilbene, Wittig Reaction

Citation

Zeka, K., Arroo, R.R.J., Hasa, D., Beresford, K.J.M. and Ruparelia, K.C. (2018) New resveratrol analogues for potential use in diabetes and cancer. Diseases. Biomedical Journal of Scientific & Technical Research, 6 (2)

Rights

Research Institute

Leicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)